Merit Medical Systems Poised for Growth: Operational Efficiency and Strategic Product Developments Fuel Buy Rating
Hold Rating on Merit Medical Systems Amid Mixed Financial Impact of EsophyX Z+ Acquisition
Merit Medical Systems Analyst Ratings
Buy Rating Affirmed for Merit Medical Systems Following Strategic EsophyX Z+ Acquisition
Merit Medical Systems Analyst Ratings
Analysts Conflicted on These Healthcare Names: Merit Medical Systems (MMSI) and Regeneron (REGN)
Barrington Raises Adjusts Price Target on Merit Medical Systems to $100 From $98, Maintains Outperform Rating
Merit Medical Systems Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)
Maintaining Hold: Balancing Merit Medical Systems' Strong Q1 Performance With a Cautious 2024 Outlook
Piper Sandler Keeps Their Buy Rating on Merit Medical Systems (MMSI)
Merit Medical Systems Analyst Ratings
Outperform Rating Maintained for Merit Medical Systems Amid Strong Growth and Profitability Projections
Merit Medical Systems Analyst Ratings
Merit Medical Systems Analyst Ratings
Merit Medical Systems (MMSI) Poised for Growth: Buy Rating Affirmed on Strategic Initiatives and New Product Launch
Hold Rating on Merit Medical Systems Amid Modest Growth Projections and Market Caution
Merit Medical Systems Analyst Ratings
Oppenheimer Raises Merit Medical Systems Price Target to $87 From $82, Maintains Outperform Rating
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Jazz Pharmaceuticals (JAZZ) and Natera (NTRA)